Lydia Jiménez-Díaz

14PUBLICATIONS
19CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersInnate immunityAutoimmunitySexualities
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 07, 2025
Clinical Benefits and Risks of Antiamyloid Antibodies in Sporadic Alzheimer Disease: Systematic Review and Network Meta-Analysis With a Web Application.

Danko Jeremic, Juan D Navarro-Lopez, Lydia Jimenez-Diaz

|Oct 17, 2024
Systematic review and meta analysis of cross immunity and the smokers paradox in COVID19.

Jesús Gonzalez-Rubio, Juan D Navarro-López, Lydia Jiménez-Díaz

|Jul 11, 2024
Anti-amyloid antibodies in Alzheimer's disease: what did clinical trials teach us?

Danko Jeremic, Lydia Jiménez-Díaz, Juan D Navarro-López

|May 29, 2024
Sex differences in Alzheimer's disease: an urgent research venue to follow.

Raquel Jiménez-Herrera, Ana Contreras, Juan D Navarro-López

|Sep 16, 2023
Systematic characterization of a non-transgenic Aβ1-42 amyloidosis model: synaptic plasticity and memory deficits in female and male mice.

Raquel Jiménez-Herrera, Ana Contreras, Souhail Djebari

Pageof 3